Melanoma detection enhanced with blood biomarkers

by Chris Thomas
More than 12,500 new cases of melanoma are diagnosed in Australia annually, making it the third most common form of cancer in Australian men and women. Credit: Ho John Lee

The need for invasive skin biopsies could be reduced extensively with Edith Cowan University researchers working on ways to detect melanoma in early stages, using a blood test in conjunction with visual scans.

A $450,000 National Health and Medical Research Council development grant has enabled them to expand on a 2012 preliminary investigation of 40 people that identified eight blood biomarkers that indicated the early presence of melanoma tumour.

ECU School of Medical Sciences Professor Mel Ziman conducted the original investigation and is working with PhD student Pauline Zaenker and postdoctoral research fellow Dr Elin Gray on the latest study.

Melanoma causes 80 per cent of skin cancer-related deaths with Australia having the highest incidence of melanoma in the world, according to the Melanoma Institute Australia.

More than 12,500 new cases of melanoma are diagnosed in Australia annually, making it the third most common form of cancer in Australian men and women.

Search for diagnostic markers turns to auto-antibodies

In 2012, Prof Zilman's investigation looked for circulating tumour cells as prognostic markers while the current research is assessing auto-antibodies as early diagnostic markers.

"No other researchers have looked for auto-antibodies in serum for diagnostic markers," she says.

"Using an array of more than 1600 protein antigens makes this particularly novel.

"Auto-antibodies are produced by the body in response to the presence of cancerous proteins.

"They were determined using serum from patients placed on an array of antigens extracted from cancerous cells and individually attached to an array."

Previously, increases in serum levels of certain auto-antibodies have been shown to precede the development of disease symptoms and correlate with the incidence of breast, lung, small cell lung, colon, ovary, prostate and head and neck cancers.

Survival rates high with early diagnosis

Prof Zilman says the chance of a patient surviving melanoma is as high as 98 per cent if caught and removed before it has a chance to spread.

"Early diagnosis is the key to improving survival rates," she says. "A reliable could be used to screen at-risk patients annually, reducing the need for unnecessary surgical procedures."

The latest study will involve 300 people—and the research team is looking for volunteers.

Participants need to have been diagnosed with melanoma within the past three months. Healthy volunteers are also needed as age-matched controls (they could possibly be partners of those diagnosed with ).

More information: "Serologic autoantibodies as diagnostic cancer biomarkers—a review." Zaenker P., et al. Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2161-81. DOI: 10.1158/1055-9965.EPI-13-0621. Epub 2013 Sep 20.

add to favorites email to friend print save as pdf

Related Stories

Higher risk of death from skin cancer among men living alone

Apr 01, 2014

There are differences in prognosis in cutaneous malignant melanoma depending on cohabitation status and gender, according to a new study published in the scientific periodical Journal of Clinical Oncology. Single men of all ...

Survival hope for melanoma patients thanks to new vaccine

Apr 17, 2014

(Medical Xpress)—University of Adelaide researchers have discovered that a new trial vaccine offers the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability ...

Recommended for you

The fine line between breast cancer and normal tissues

7 hours ago

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

8 hours ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Good bowel cleansing is key for high-quality colonoscopy

11 hours ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

New rules for anticancer vaccines

12 hours ago

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

User comments